stockrowBiogen Inc.
BIIB Healthcare Drug Manufacturers General
Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- −104.4%
- Free cash flow
- −69.3%
- Total debt
- +16.0%
Quarter to September 2026, against a year earlier
Follow BIIB
Alert me
Biogen Inc. (BIIB) Gross margin
Biogen Inc.'s gross margin over the twelve months to 30 September 2026 was 74.0%, down 1.7 percentage points from fiscal 2025 (75.7%). Over the past ten years it has ranged from 74.2% (fiscal 2023) to 88.5% (fiscal 2015); the current reading is higher than 18% of that period. That is in line with the Drug Manufacturers General industry median of 73.0% and above the Healthcare sector median of 53.9%.
Gross margin, annual
Embed this chart
Annual newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 75.7% | (0.43) |
| FY2024 | 76.1% | 1.88 |
| FY2023 | 74.2% | (3.37) |
| FY2022 | 77.6% | (3.18) |
| FY2021 | 80.8% | (5.78) |
| FY2020 | 86.6% | 0.17 |
| FY2019 | 86.4% | (0.10) |
| FY2018 | 86.5% | (0.22) |
| FY2017 | 86.7% | (0.36) |
| FY2016 | 87.1% | (1.40) |
Quarterly newest first
| Period | Gross margin | Change (points) |
|---|---|---|
| Sep 2026 | 73.3% | 1.71 |
| Jun 2026 | 71.6% | (1.72) |
| Mar 2026 | 73.3% | (4.94) |
| Dec 2025 | 78.3% | 4.87 |
| 43 more quarters | Free account |
Against its own ten years
Gross margin against peers
| Company | Gross margin |
|---|---|
| AZN AstraZeneca PLC compare | 81.9% |
| NVO Novo Nordisk A/S compare | 80.7% |
| GILD Gilead Sciences, Inc. compare | 79.9% |
| BIIB Biogen Inc. | 74.0% |
| SNY Sanofi compare | 73.4% |
| PFE Pfizer Inc. compare | 73.4% |
| GSK GSK PLC Sponsored ADR compare | 72.6% |
| AMGN Amgen Inc. compare | 70.9% |
| BMY Bristol Myers Squibb Company compare | 69.2% |
| Drug Manufacturers General industry median | 73.0% |
| Healthcare sector median | 53.9% |
| Market median | 45.1% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on BIIB
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement